Indeed, PRMT5 and type I PRMT inhibition suppressed sDMA and aDMA functions in RNA-binding proteins involved in splicing regulation, leading to tumor-suppression responses in animal leukemia models with splicing factor mutations (24). The gene discussed is PRMT5; the disease is neoplasm.